Head Cancer and Metastasic Neck. What Have We
Advanced in the Last Years?
Volume 2 - Issue 1
Beatrz Losada Vila1*, David Gutiérrez Abad1, Beatriz Anton Pascual1, Maria Carmen Pantin1, Begoña Caballero Perea2
and Juan Antonio Guerra1
-
Author Information
Open or Close
- 1Oncology Department, Universitary Hospital Fuenlabrada, Madrid, Spain
- 2Radiation Oncology, Universitary Hospital Fuenlabrada, Madrid, Spain
*Corresponding author:
Beatrz Losada Vila, Oncology Department. University Hospital Fuenlabrada, Madrid, Spain
Received: May 26, 2018; Published: June 15, 2018
DOI: 10.32474/OAJOM.2018.02.000129
Full Text
PDF
To view the Full Article Peer-reviewed Article PDF
Abstract
In 2012, 5.210 new cases of head and neck tumors were estimated in the USA, with an increasing incidence due to tobacco and
alcohol habits in the population. A large percentage of the cases debut as a locally advanced disease, so control of the disease is key
and we look for the best therapeutic strategy to achieve good survival rates while maintaining quality of life. We present the case of
a 60-year-old patient in which our objectives to be presented are the assessment of comorbidity, toxicity and survival.
Abstract|
Clinical Case|
Discussion|
References|